Is ED Still Only Equal to ED?

European Urology

Volumn 55, Issue 4, 2009, Pages 794-797

  Salonia, Andrea ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL;

CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; EDITORIAL; ENDOTHELIAL DYSFUNCTION; ERECTILE DYSFUNCTION; HUMAN; MESENCHYMAL STEM CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; RISK FACTOR; STEM CELL TRANSPLANTATION;

ENDOTHELIUM, VASCULAR; HUMANS; IMPOTENCE, VASCULOGENIC; MALE;

EID: 60249090717     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.08.068     Document Type: Editorial

References (44)

1. Feldman H.A., Goldstein I., Hatzichristou D.G., Krane R.J., and McKinlay J.B. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 151 (1994) 54-61
2. Mannino D.M., Klevens R.M., and Flanders W.D. Cigarette smoking: an independent risk factor for impotence?. Am J Epidemiol 140 (1994) 1003-1008
3. Vlachopoulos C., Rokkas K., Ioakeimidis N., et al. Prevalence of asymptomatic coronary artery disease in men with vasculogenic erectile dysfunction: a prospective angiographic study. Eur Urol 48 (2005) 996-1003
4. Ma R.C., So W.Y., Yang X., et al. Erectile dysfunction predicts coronary heart disease in type 2 diabetes. J Am Coll Cardiol 51 (2008) 2045-2050
5. Montorsi F., Briganti A., Salonia A., et al. Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol 44 (2003) 360-365
6. Stuckey B.G., Walsh J.P., Ching H.L., et al. Erectile dysfunction predicts generalised cardiovascular disease: evidence from a case-control study. Atherosclerosis 194 (2007) 458-464
7. Heruti R.J., Uri I., Arbel Y., Swartzon M., Galor S., and Justo D. Erectile dysfunction severity might be associated with poor cardiovascular prognosis in diabetic men. J Sex Med 4 (2007) 465-471
8. Brocq M.L., Leslie S.J., Milliken P., and Megson I.L. Endothelial dysfunction: from molecular mechanisms to measurement, clinical implications, and therapeutic opportunities. Antioxid Redox Signal 10 (2008) 1631-1674
9. Kovács I., Császár A., Toth J., et al. Correlation between flow-mediated dilation and erectile dysfunction. J Cardiovasc Pharmacol 51 (2008) 148-153
10. Vardi Y., Dayan L., Apple B., Gruenwald I., Ofer Y., and Jacob G. Penile and systemic endothelial function in men with and without erectile dysfunction. Eur Urol 55 (2009) 979-985
11. Eaton C.B., Liu Y.L., Mittleman M.A., Miner M., Glasser D.B., and Rimm E.B. A retrospective study of the relationship between biomarkers of atherosclerosis and erectile dysfunction in 988 men. Int J Impot Res 19 (2007) 218-225
12. Kugiyama K., Ohgushi M., Motoyama T., et al. Nitric oxide-mediated flow-dependent dilation is impaired in coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 30 (1997) 920-926
13. Solomon H., Man J.W., and Jackson G. Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator. Heart 89 (2003) 251-253
14. Maas R., Schwedhelm E., Albsmeier J., and Böger R.H. The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function. Vasc Med 7 (2002) 213-225
15. Landmesser U., and Drexler H. The clinical significance of endothelial dysfunction. Curr Opin Cardiol 20 (2005) 547-551
16. Widlansky M.E., Gokce N., Keaney Jr. J.F., and Vita J.A. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 42 (2003) 1149-1160
17. Tamler R., and Bar-Chama N. Assessment of endothelial function in the patient with erectile dysfunction: an opportunity for the urologist. Int J Impot Res 20 (2008) 370-377
18. Korkmaz H., and Onalan O. Evaluation of endothelial dysfunction: flow-mediated dilation. Endothelium 15 (2008) 157-163
19. Neunteufl T., Katzenschlager R., Hassan A., et al. Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis 129 (1997) 111-118
20. Kirma C., Akcakoyun M., Esen A.M., et al. Relationship between endothelial function and coronary risk factors in patients with stable coronary artery disease. Circ J 71 (2007) 698-702
21. Perrone-Filardi P., Cuocolo A., Brevetti G., et al. Relation of brachial artery flow-mediated vasodilation to significant coronary artery disease in patients with peripheral arterial disease. Am J Cardiol 96 (2005) 1337-1341
22. Jambrik Z., Venneri L., Varga A., Rigo F., Borges A., and Picano E. Peripheral vascular endothelial function testing for the diagnosis of coronary artery disease. Am Heart J 148 (2004) 684-689
23. Celermajer D.S. Reliable endothelial function testing: at our fingertips?. Circulation 117 (2008) 2428-2430
24. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
25. Rafii S., and Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularisation and regeneration. Nat Med 9 (2003) 702-712
26. Asahara T., and Kawamoto A. Endothelial progenitor cells for postnatal vasculogenesis. Am J Physiol Cell Physiol 287 (2004) C572-C579
27. Aicher A., Zeiher A.M., and Dimmeler S. Mobilizing endothelial progenitor cells. Hypertension 45 (2005) 321-325
28. Dimmeler S., and Zeiher A.M. Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis?. J Mol Med 82 (2004) 671-677
29. Foresta C., Caretta N., Lana A., et al. Reduced number of circulating endothelial progenitor cells in hypogonadal men. J Clin Endocrinol Metab 91 (2006) 4599-4602
30. Baumhäkel M., Werner N., Böhm M., and Nickenig G. Circulating endothelial progenitor cells correlate with erectile function in patients with coronary heart disease. Eur Heart J 27 (2006) 2184-2188
31. Rosano G.M.C., Aversa A., Vitale C., Fabbri A., Fini M., and Spera G. Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk. Eur Urol 47 (2005) 214-222
32. Sommer F., and Schulze W. Treating erectile dysfunction by endothelial rehabilitation with phosphodiesterase 5 inhibitors. World J Urol 23 (2005) 385-392
33. Aversa A., Greco E., Bruzziches R., Pili M., Rosano G., and Spera G. Relationship between chronic tadalafil administration and improvement of endothelial function in men with erectile dysfunction: a pilot study. Int J Impot Res 19 (2007) 200-207
34. Sánchez A., Villalba N., Martínez A.C., García-Sacristán A., Hernández M., and Prieto D. Mechanisms of the relaxant effect of vardenafil in rat penile arteries. Eur J Pharmacol 586 (2008) 283-287
35. Guazzi M., Samaja M., Arena R., Vicenzi M., and Guazzi M.D. Long-term use of sildenafil in the therapeutic management of heart failure. Am Coll Cardiol 50 (2007) 2136-2144
36. Schäfer A., Fraccarollo D., Pförtsch S., et al. Improvement of vascular function by acute and chronic treatment with the PDE-5 inhibitor sildenafil in experimental diabetes mellitus. Br J Pharmacol 153 (2008) 886-893
37. Behr-Roussel D., Oudot A., Caisey S., et al. Daily treatment with sildenafil reverses endothelial dysfunction and oxidative stress in an animal model of insulin resistance. Eur Urol 53 (2008) 1272-1281
38. Foresta C., Caretta N., Lana A., Cabrelle A., Palù G., and Ferlin A. Circulating endothelial progenitor cells in subjects with erectile dysfunction. Int J Impot Res 17 (2005) 288-290
39. Foresta C., Caretta N., Lana A., et al. Relationship between vascular damage degrees and endothelial progenitor cells in patients with erectile dysfunction: effect of vardenafil administration and PDE5 expression in the bone marrow. Eur Urol 51 (2007) 1411-1419
40. Bivalacqua T.J., Deng W., Kendirci M., et al. Mesenchymal stem cells alone or ex vivo gene modified with endothelial nitric oxide synthase reverse age-associated erectile dysfunction. Am J Physiol Heart Circ Physiol 292 (2007) H1278-H1290
41. Strong T.D., Gebska M.A., Champion H.C., Burnett A.L., and Bivalacqua T.J. Stem and endothelial progenitor cells in erection biology. Int J Impot Res 20 (2008) 243-254
42. Nolazco G., Kovanecz I., Vernet D., et al. Effect of muscle-derived stem cells on the restoration of corpora cavernosa smooth muscle and erectile function in the aged rat. BJU Int 101 (2008) 1156-1164
43. Sievert K.-D., Amend B., and Stenzl A. Tissue engineering for the lower urinary tract: a review of a state of the art approach. Eur Urol 52 (2007) 1580-1589
44. Abdi R., Fiorina P., Adra C.N., Atkinson M., and Sayegh M.H. Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes 57 (2008) 1759-1767